Relmada Therapeutics, Inc. RLMD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $3.5M-9.3% | $3.86M-5.7% | $4.09M-24.2% | $5.4M-87.9% | ||
| $89.51M+118% | $41.05M-55.5% | $92.23M-35.5% | $142.93M-14.7% | ||
| $93.98M+105% | $45.8M-53.0% | $97.51M-36.2% | $152.87M-31.5% | ||
| $3.54M+67.1% | $2.12M-18.5% | $2.6M— | —— | ||
| $11K0.0% | $11K0.0% | $11K-100.0% | $45.67M+19.0% | ||
| $19.5K-11.3% | $21.98K-49.0% | $43.13K+2,056% | $2K-92.9% | ||
| $1.61M+15.0% | $1.4M-13.5% | $1.62M+4.5% | $1.55M+136% | ||
| —— | —— | —— | —— | ||
| $94M+105% | $45.82M-53.0% | $97.55M-36.2% | $152.91M-31.5% | ||
| $1.57M-62.0% | $4.13M+17.8% | $3.51M-33.4% | $5.26M-53.0% | ||
| $4.86M-21.1% | $6.16M+5,234% | $115.5K-55.4% | $258.7K+97.5% | ||
| $6.43M-37.5% | $10.29M-15.6% | $12.19M-2.2% | $12.47M-17.2% | ||
| $7.49M-27.2% | $10.3M-15.6% | $12.19M-2.2% | $12.47M-17.2% | ||
| 150M0.0% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| $784.71M+16.0% | $676.37M+4.7% | $646.23M+7.3% | $602.52M+17.4% | ||
| -$698.27M-9.0% | -$640.88M-14.3% | -$560.9M-21.4% | -$462.11M-51.5% | ||
| $86.51M+144% | $35.52M-58.4% | $85.36M-39.2% | $140.44M-32.6% | ||
| $94M+105% | $45.82M-53.0% | $97.55M-36.2% | $152.91M-31.5% | ||
| $977.7K+10.3% | $886.5K— | —— | —— | ||
| $11K0.0% | $11K0.0% | $11K-99.6% | $2.73M-37.8% | ||
| $4.77M+20.5% | $3.95M— | —— | —— | ||
| $4.77M-91.0% | $53.03M+27.6% | $41.56M+202% | $13.78M+10.2% | ||
| $19.5K-11.3% | $21.98K-49.0% | $43.13K+23.7% | $34.88K+23.3% | ||
| $89.51M+118% | $41.05M-55.5% | $92.23M-35.5% | $142.93M-14.7% | ||
| $19.5K-11.3% | $21.98K-49.0% | $43.13K+23.7% | $34.88K+23.3% | ||
| $122.5M+6.2% | $115.36M+4.7% | $110.14M-5.4% | $116.4M+21.0% | ||
| $4.86M-21.1% | $6.16M-29.1% | $8.69M+20.6% | $7.21M+86.3% | ||
| $4.86M-21.1% | $6.16M-29.1% | $8.69M+20.6% | $7.21M+86.3% | ||
| $535.5K+27.0% | $421.7K+13.3% | $372.2K-29.7% | $529.8K+17.6% | ||
| $220K-39.3% | $362.6K+108% | $174K+49.4% | $116.5K-30.7% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 73.3M+143% | 30.2M+0.2% | 30.1M0.0% | 30.1M+46,206% | ||
| $20.01M— | —— | $11.18M— | —— | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| $73.33K+143% | $30.17K+0.2% | $30.1K0.0% | $30.1K+8.5% | ||
| —— | —— | 7.2M+64.4% | 4.4M+104% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 5.9M— | —— | —— | —— | ||
| 15M— | —— | 17.4M+475% | 3M-5.7% | ||
| $2.86-100.0% | $16,289,000.00— | —— | —— | ||
| $2.20— | —— | —— | —— | ||
| $12.51— | —— | $12.99-23.7% | $17.02— | ||
| —— | $732.3K-72.2% | $2.63M— | —— | ||
| —— | —— | —— | —— | ||
| $220K-39.3% | $362.6K+108% | $174K+49.4% | $116.5K-30.7% | ||
| $3.97M-12.0% | $4.51M-16.3% | $5.39M— | —— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $150M0.0% | $150M0.0% | $150M0.0% | $150M0.0% | ||
| $73.33M+143% | $30.17M+0.2% | $30.1M0.0% | $30.1M+8.5% | ||
| $73.33M+143% | $30.17M+0.2% | $30.1M0.0% | $30.1M+8.5% | ||
| $35.9M-16.2% | $42.84M— | —— | —— | ||
| $3.54M+67.1% | $2.12M-18.5% | $2.6M— | —— | ||
| $122.5M+6.2% | $115.36M— | —— | —— | ||
| $21.98M-24.3% | $29.04M-0.9% | $29.31M— | —— | ||
| $2.72M+75.0% | $1.55M-58.8% | $3.77M-72.6% | $13.78M+10.2% | ||
| $231K— | —— | —— | —— | ||
| $1.61M+15.0% | $1.4M-13.5% | $1.62M+4.5% | $1.55M+136% | ||
| —— | $7.76M— | —— | —— | ||
| $122.5M+6.2% | $115.36M+4.7% | $110.14M-5.4% | $116.4M+21.0% | ||
| —— | —— | —— | —— | ||
| $4.77M-91.0% | $53.03M+27.6% | $41.56M— | —— | ||
| $134.4K+3.9% | $129.4K+12.0% | $115.5K— | —— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $200M0.0% | $200M0.0% | $200M0.0% | $200M0.0% | ||
| $977.72K+10.3% | $886.46K-25.2% | $1.19M-70.6% | $4.04M-64.3% | ||
| $411.9K+2.2% | $403.1K+10.4% | $365.1K+16.6% | $313.2K-11.4% | ||
| —— | —— | —— | —— | ||
| $496.5K+26.9% | $391.2K-43.7% | $695K-80.8% | $3.62M-66.2% | ||
| $1.06M+23,650% | $4.47K— | —— | —— | ||
| $2M— | —— | —— | —— | ||
| $2.86— | —— | —— | —— | ||
| —— | —— | $7.16M+64.4% | $4.36M+104% | ||
| $15.02M— | —— | $17.42M— | —— | ||
| $12.51— | —— | $12.99— | —— | ||
| $5.88M— | —— | —— | —— | ||
| $20.01M— | —— | $11.18M— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | $20.25-7.2% | $21.83+4.0% | ||
| $2.2— | —— | —— | —— | ||
| —— | —— | $1.02M+1,266% | $74.35K-99.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Relmada Therapeutics, Inc.'s total assets?
- Relmada Therapeutics, Inc. (RLMD) holds $235.4M in total assets, up 750.3% year over year.
- How much cash does Relmada Therapeutics, Inc. have?
- Relmada Therapeutics, Inc. holds $9.8M in cash and equivalents.
- Can Relmada Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 18.26 — current assets exceed current liabilities.
- Where does Relmada Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Relmada Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.